Search for: "Laboratory Express, Inc." Results 281 - 300 of 438
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jun 2011, 7:45 am by Brett J. Rosen
Radio Engineering Laboratories, Inc., 293 U.S. 1, the Supreme Court stated that “there is a presumption of [patent] validity [that is] not to be overthrown except by clear and cogent evidence. [read post]
22 Jun 2011, 2:00 am by Stefanie Levine
On June 20, 2011, the United States Supreme Court granted Mayo's petition for certiorari in Prometheus Laboratories, Inc. v. [read post]
22 Jun 2011, 2:00 am by Stefanie Levine
On June 20, 2011, the United States Supreme Court granted Mayo's petition for certiorari in Prometheus Laboratories, Inc. v. [read post]
9 Jun 2011, 10:22 pm
Radio Engineering Laboratories, Inc., 293 U. [read post]
8 Jun 2011, 12:43 pm by Bexis
Mylan Laboratories, Inc., 2008 WL 4813311 (D. [read post]
2 Jun 2011, 6:02 am by John Elwood
Teva Pharmaceuticals USA, Inc., 10-1070, which we included in last week’s Petitions to Watch. [read post]
27 May 2011, 8:56 am by Kali Borkoski
  Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
19 May 2011, 7:16 am by Broc Romanek
The 37-page letter opinion authored by Vice Chancellor John Noble articulates the basis for an order denying an application to enjoin Laboratory Corporation of America Holdings, Inc.'s proposed $85.4 million acquisition of Orchid Cellmark Inc. by first step tender offer and second step merger. [read post]
16 May 2011, 8:08 pm by The Legal Blog
This is significant because an expression of surprise could be mistaken for physiological responses that are similar to those associated with deception. [read post]
6 Apr 2011, 12:18 am by Marie Louise
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]